Aphria price target 2020

    • Detailed Stock Report - The Globe and Mail

      Current Price (CAD) Price Target 20.53 MEAN HIGH LOW 12-Month Price Target Mean (CAD) 31.10 High 60.00 Low 13.70 Target vs. Current 51.5% # of Analysts 21 CANOPY GROWTH CORP (WEED-T) Pharma. & Med. Research / Pharmaceuticals / Pharmaceuticals STOCKREPORTS+ DETAILED STOCK REPORT Report Date: 2020 March 31 The Financial and Risk business of ...

      aphria stock price today tsx


    • [PDF File]Invitation to subscription of shares in ODI Pharma AB

      https://info.5y1.org/aphria-price-target-2020_1_baa483.html

      cannabis material from Aphria in early-2020, meaning that the Company intends to start operations on the Polish strategy in early-2020 as well. ODI Pharma intends to initiate educational programs for medical practitioners in Poland, which is part of a branding strategy since companies are not allowed to market

      aphria stock forecast


    • Detailed Stock Report - The Globe and Mail

      HIGHLIGHTS PRICE TARGET - Aphria Inc currently has an Earnings Rating of 7, which is significantly more bullish than the Pharmaceuticals industry average of 4.6. - Over the past 90 days, the consensus price target for APHA has decreased notably from 12.50 to 11.10, a loss of -11.2%. - APHA's current quarter consensus estimate has decreased notably

      aphria analyst ratings


    • [PDF File]Aura Health Inc. (BUZZ)

      https://info.5y1.org/aphria-price-target-2020_1_e785b1.html

      We initiate coverage of Aura Health with a buy recommendation and a price target of $0.21, which is 250% above today’s stock price. 4. Building a Retail Dispensary Brand: We are very bullish on the Company's recent closing on their majority acquisition of CannabiSendak in Israel. Israel is a global leader in medical

      aphria target price 2019


    • [PDF File]Canada Leads the Global Cannabis Paradigm Shift

      https://info.5y1.org/aphria-price-target-2020_1_dc883a.html

      Valuation: Our target price of $17 is based on a projected enterprise value that is about 17x our Base Case fiscal 2020 EBITDA estimate. We note that our Base Case fiscal 2020 EBITDA estimate assumes that Aphria’s facility expansions are only at 65% of full ramp potential versus management’s expectation

      apha stock target price


    • [PDF File]Playing cannabis in the Sunshine State

      https://info.5y1.org/aphria-price-target-2020_1_23a062.html

      legalize recreational cannabis (with lobbying in place to have it on the ballot in 2020), ... with Aphria Inc., one of Canada’s largest Licensed Producers), while continuing to roll ... Our C$24.00 target price …

      aphria stock forecast 2019


    • [PDF File]DRIVING THE GLOBAL CANNABIS INDUSTRY

      https://info.5y1.org/aphria-price-target-2020_1_c84bd1.html

      2,020 2,330 2,528 Q417 Q118 Q218 Q318 Q418 Avg. Sales Price per Gram $8.03 $7.96 $7.99 $8.30 $8.43 Q4 17 Q1 18 Q218 Q318 Q418 Patients (1000) 29 55 59 64 69 74 Q317 Q417 Q118 Q218 Q318 Q418 1) Excluding shipping and fulfillment 18

      buy aphria stock online


    • [PDF File]ALEAFIA HEALTH INC. – BUY Initiating Coverage With BUY and ...

      https://info.5y1.org/aphria-price-target-2020_1_cea6b9.html

      INITIATING WITH A BUY RECOMMENDATION AND A $1.75 TARGET PRICE We are initiating coverage of Aleafia Health Inc. with a BUY rating and target price of $1.75 per share. To arrive at our target price, we applied a 12x EV/EBITDA multiple to our 2020 estimate and then discounted the result using a 15% discount rate. INDUSTRY OVERVIEW

      aphria stock price target


    • [PDF File]Our Final Word on $TLRY before $50

      https://info.5y1.org/aphria-price-target-2020_1_7158d0.html

      valuation enough to justify current stock price levels. Cowen initiated on TLRY on August 13 and used a 9x multiple on 2020 revenue to derive their price target of $34. Just two weeks later, the analyst raised their 2020 revenue multiple to 17x to get to a new price target of $62.

      aphria stock price today tsx


    • [PDF File]Pharmadrug Inc. (BUZZ)

      https://info.5y1.org/aphria-price-target-2020_1_5101d3.html

      We reiterate our buy recommendation for Pharmadrug with a price target of $0.21, which is 600% above today’s stock price. 4. Building a Retail Dispensary Brand: We are ... Aphria, and… Pharmadrug. Arguably, this is the ideal method to gain ... second half of 2020, while third party Israeli

      aphria stock forecast


Nearby & related entries: